文献速递肝病消化道肿瘤与早癌

糖尿病及血糖控制对乙型肝炎表面抗原清除后肝细胞癌风险的影响

Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen.
PubMed 文献 · Clin Gastroenterol Hepatol · 2017-12-12

基于香港全港数据库的回顾性研究纳入2000年1月至2016年8月HBsAg清除的慢性HBV感染者4568例,其中糖尿病1560例。中位随访3.4年后,糖尿病是HBsAg清除后HCC的独立危险因素(aHR 1.85,95%CI 1.04-3.28,P=.036);糖尿病患者中HbA1c时间加权平均值≥7%者5年HCC累积发生率4.0%,高于<7%者的1.8%(log-rank P=.035)。

要点

  • HBsAg清除后,糖尿病仍与HCC风险升高独立相关(aHR 1.85,95%CI 1.04-3.28)。
  • 糖尿病患者HbA1c时间加权平均值每升高单位,HCC风险增加(aHR 1.51,95%CI 1.20-1.91)。
  • HbA1c时间加权平均值≥7%者5年HCC累积发生率4.0%,高于<7%者的1.8%。

核心结论

  • 在香港慢性HBV感染人群中,糖尿病是HBsAg清除后发生HCC的独立危险因素,而血糖控制似乎可降低HCC风险。

研究设计与样本

  • 回顾性研究,利用香港医院管理局临床数据分析与报告系统,纳入2000年1月至2016年8月HBsAg清除的慢性HBV感染者4568例。
  • 糖尿病定义依据ICD-9-CM诊断编码,或HbA1c>6.5%,或空腹血糖≥7 mmol/L,或使用任何降糖药物。

主要发现

  • 共识别糖尿病患者1560例,中位随访3.4年(四分位距1.5-5.0年)期间29例(1.9%)发生HCC。
  • 调整年龄、性别、肝硬化及用药后,糖尿病与HCC风险升高相关(aHR 1.85,95%CI 1.04-3.28,P=.036)。
  • 糖尿病患者中,调整HBsAg清除时年龄、他汀使用及其他重要协变量后,HbA1c时间加权平均值是HCC的独立危险因素(aHR 1.51,95%CI 1.20-1.91,P<.001)。
  • HbA1c时间加权平均值≥7%者5年HCC累积发生率为4.0%,高于<7%者的1.8%(log-rank检验P=.035)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Diabetes is associated with a 2-fold increase in risk of hepatocellular carcinoma (HCC) among patients with chronic hepatitis B virus (HBV) infection. However, we know little about the effect of diabetes on HCC risk after seroclearance of hepatitis B surface antigen (HBsAg). We evaluated the effect of diabetes and glycemic control on HCC development after HBsAg seroclearance in a population-wide study in Hong Kong. METHODS: We performed a retrospective study of 4568 patients with chronic HBV infection who cleared HBsAg from January 2000 through August 2016, using the Clinical Data Analysis and Reporting System of the Hospital Authority, Hong Kong. We collected and analyzed data on patient demographics, comorbidities, medications, laboratory test results, and subsequent development of HCC. The presence of diabetes was defined by International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis code, with level of hemoglobin A1c (HbA1c) above 6.5%, fasting glucose level of 7 mmol/L or more, or treatment with any antidiabetic agent. RESULTS: We identified 1560 patients with diabetes; 29 patients (1.9%) developed HCC after a median follow-up time of 3.4 years (interquartile range, 1.5-5.0 years). Diabetes was associated with increased risk of HCC after adjustment of age, sex, presence of cirrhosis, and the use of medications (adjusted hazard ratio, 1.85; 95% CI, 1.04-3.28; P = .036). Among patients with diabetes, time-weighted average level of HbA1c was an independent risk factor for HCC, after adjustment for age at clearance, use of statins, and other important covariates (adjusted hazard ratio: 1.51; 95% CI, 1.20-1.91; P < .001). A time-weighted average level of HbA1c of 7% or more was associated with a higher 5-year cumulative incidence of HCC (4.0%) than a time-weighted average HbA1c level below 7% (1.8%; log-rank test P = .035). CONCLUSIONS: In a population-based analysis of patients with chronic HBV infection in Hong Kong, we found diabetes to be an independent risk factor for HCC after HBsAg seroclearance. However, glycemia control appears to reduce the risk of HCC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Cheuk-Fung Yip T, Wai-Sun Wong V, Lik-Yuen Chan H, et al. Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen. Clin Gastroenterol Hepatol. 2017. PMID: 29246694. doi:10.1016/j.cgh.2017.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。